Posts

35)Republic Day Parade 2019: Indias rich cultural diversity on display at Rajpath; 10 points

India Republic Day -- With Indias 70th Republic Day time Saturday the annual attend in the national capital presented the countrys rich ethnical heritage and traditions. The actual central theme of the tableaux displayed was Mahatma Gandhi as 2019 marks the entire year of his 150th beginning anniversary. The might with the Indian military was in full display and in specific womens power. Before the attend celebrations kicked off along with Prime Minister Narendra Modi paying homage to the martyrs by laying a bridal flowers wreath at Amar Jawan Jyoti. At Rajpath the Prime Minister received President Ram memory Nath Kovind and To the south Africas President Cyril Ramaphosa who was the Chief Guest from Indias Republic Day 2019 event. President Kovind hoisted the tricolour as the countrywide anthem played and a 21-gun salute was fired through seven cannons of 2281 Field Regiment. Republic Day time Parade 2019 * Assam Rifles tableau: Participating in the particular Republic Day parade
Post a Comment
Read more

Gene therapy

Image
Gene therapy (also called human gene transfer ) is a medical field which focuses on the utilization of the therapeutic delivery of nucleic acids into a patient's cells as a drug to treat disease. The first attempt at modifying human DNA was performed in 1980 by Martin Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989. The first therapeutic use of gene transfer as well as the first direct insertion of human DNA into the nuclear genome was performed by French Anderson in a trial starting in September 1990. It is thought to be able to cure many genetic disorders or treat them over time. Between 1989 and December 2018, over 2,900 clinical trials were conducted, with more than half of them in phase I. As of 2017, Spark Therapeutics' Luxturna (RPE65 mutation-induced blindness) and Novartis' Kymriah (Chimeric antigen receptor T cell therapy) are the FDA's first approved gene therapies to
Post a Comment
Read more

Background

Image
Gene therapy was conceptualized in 1972, by authors who urged caution before commencing human gene therapy studies. The first attempt, an unsuccessful one, at gene therapy (as well as the first case of medical transfer of foreign genes into humans not counting organ transplantation) was performed by Martin Cline on 10 July 1980. Cline claimed that one of the genes in his patients was active six months later, though he never published this data or had it verified and even if he is correct, it's unlikely it produced any significant beneficial effects treating beta-thalassemia. medical citation needed After extensive research on animals throughout the 1980s and a 1989 bacterial gene tagging trial on humans, the first gene therapy widely accepted as a success was demonstrated in a trial that started on 14 September 1990, when Ashi DeSilva was treated for ADA-SCID. The first somatic treatment that produced a permanent genetic change was initiated in 1993. The goal was to cure malignant
Post a Comment
Read more

Cell types

Gene therapy may be classified into two types: Somatic edit In somatic cell gene therapy (SCGT), the therapeutic genes are transferred into any cell other than a gamete, germ cell, gametocyte, or undifferentiated stem cell. Any such modifications affect the individual patient only, and are not inherited by offspring. Somatic gene therapy represents mainstream basic and clinical research, in which therapeutic DNA (either integrated in the genome or as an external episome or plasmid) is used to treat disease. Over 600 clinical trials utilizing SCGT are underway when? in the US. Most focus on severe genetic disorders, including immunodeficiencies, haemophilia, thalassaemia, and cystic fibrosis. Such single gene disorders are good candidates for somatic cell therapy. The complete correction of a genetic disorder or the replacement of multiple genes is not yet possible. Only a few of the trials are in the advanced stages. needs update Germline edit In germline gene therapy (GGT), germ cel
Post a Comment
Read more

Vectors

The delivery of DNA into cells can be accomplished by multiple methods. The two major classes are recombinant viruses (sometimes called biological nanoparticles or viral vectors) and naked DNA or DNA complexes (non-viral methods). medical citation needed Viruses edit In order to replicate, viruses introduce their genetic material into the host cell, tricking the host's cellular machinery into using it as blueprints for viral proteins. Retroviruses go a stage further by having their genetic material copied into the genome of the host cell. Scientists exploit this by substituting a virus's genetic material with therapeutic DNA. (The term 'DNA' may be an oversimplification, as some viruses contain RNA, and gene therapy could take this form as well.) A number of viruses have been used for human gene therapy, including retroviruses, adenoviruses, herpes simplex, vaccinia, and adeno-associated virus. Like the genetic material (DNA or RNA) in viruses, therapeutic DNA can be
Post a Comment
Read more

Hurdles

Some of the unsolved problems include: Short-lived nature – Before gene therapy can become a permanent cure for a condition, the therapeutic DNA introduced into target cells must remain functional and the cells containing the therapeutic DNA must be stable. Problems with integrating therapeutic DNA into the genome and the rapidly dividing nature of many cells prevent it from achieving long-term benefits. Patients require multiple treatments. Immune response – Any time a foreign object is introduced into human tissues, the immune system is stimulated to attack the invader. Stimulating the immune system in a way that reduces gene therapy effectiveness is possible. The immune system's enhanced response to viruses that it has seen before reduces the effectiveness to repeated treatments. Problems with viral vectors – Viral vectors carry the risks of toxicity, inflammatory responses, and gene control and targeting issues. Multigene disorders – Some commonly occurring disorders, such a
Post a Comment
Read more

History

Image
This section may be too long and excessively detailed. Please consider summarizing the material while citing sources as needed. ( November 2018 ) 1970s and earlier edit In 1972 Friedmann and Roblin authored a paper in Science titled "Gene therapy for human genetic disease?" Rogers (1970) was cited for proposing that exogenous good DNA be used to replace the defective DNA in those who suffer from genetic defects. 1980s edit In 1984 a retrovirus vector system was designed that could efficiently insert foreign genes into mammalian chromosomes. 1990s edit The first approved gene therapy clinical research in the US took place on 14 September 1990, at the National Institutes of Health (NIH), under the direction of William French Anderson. Four-year-old Ashanti DeSilva received treatment for a genetic defect that left her with ADA-SCID, a severe immune system deficiency. The defective gene of the patient's blood cells was replaced by the functional variant. Ashanti's imm
Post a Comment
Read more